TY  - RPRT
TI  - Efficacy and Safety of Once-Weekly Semaglutide 2.0 mg as an Add-On to Dose-Reduced Insulin Glargine versus Dose-Titrated Insulin Glargine in People With Type 2 Diabetes and Overweight (SUSTAIN OPTIMIZE).
AU  - Helena W Rodbard
AU  - Concetta Irace
AU  - Jevitha Lobo
AU  - Konstantinos Makrilakis
AU  - Prachi Priyadarshini
AU  - Suvanjaa Sivalingam
AU  - Santiago Tofé Povedano
AU  - Anuj Bhargava
PY  - 2026
DO  - 10.1111/dom.71132
UR  - https://pubmed.ncbi.nlm.nih.gov/42504064/
ID  - 42504064
ER  -